[HTML][HTML] The roles of histone deacetylases and their inhibitors in cancer therapy

G Li, Y Tian, WG Zhu - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Genetic mutations and abnormal gene regulation are key mechanisms underlying
tumorigenesis. Nucleosomes, which consist of DNA wrapped around histone cores …

[HTML][HTML] Histone deacetylase inhibitors as anticancer drugs

T Eckschlager, J Plch, M Stiborova… - International journal of …, 2017 - mdpi.com
Carcinogenesis cannot be explained only by genetic alterations, but also involves
epigenetic processes. Modification of histones by acetylation plays a key role in epigenetic …

[HTML][HTML] Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors

L He, JH Jhong, Q Chen, KY Huang, K Strittmatter… - Cell reports, 2021 - cell.com
Macrophages undergoing M1-versus M2-type polarization differ significantly in their cell
metabolism and cellular functions. Here, global quantitative time-course proteomics and …

The role of enhancers in cancer

I Sur, J Taipale - Nature Reviews Cancer, 2016 - nature.com
Enhancer elements function as the logic gates of the genetic regulatory circuitry. One of their
most important functions is the integration of extracellular signals with intracellular cell fate …

[HTML][HTML] HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases

G Shanmugam, S Rakshit, K Sarkar - Translational Oncology, 2022 - Elsevier
Histone deacetylases (HDACs) are enzymes that play a key role in the epigenetic regulation
of gene expression by remodeling chromatin. Inhibition of HDACs is a prospective …

Epigenetics in cancer

M Esteller - New England Journal of Medicine, 2008 - Mass Medical Soc
Gene transcription can be activated or inhibited by a reversible modification of the gene; this
modification is termed an epigenetic change. This account of epigenetics in cancer reviews …

[HTML][HTML] Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs

HJ Kim, SC Bae - American journal of translational research, 2011 - ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that
play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis …

[HTML][HTML] Targeting histone deacetylases with natural and synthetic agents: an emerging anticancer strategy

AK Singh, A Bishayee, AK Pandey - Nutrients, 2018 - mdpi.com
Cancer initiation and progression are the result of genetic and/or epigenetic alterations.
Acetylation-mediated histone/non-histone protein modification plays an important role in the …

Histone deacetylases (HDACs): characterization of the classical HDAC family

AJM Ruijter, AH GENNIP, HN Caron, S Kemp… - Biochemical …, 2003 - portlandpress.com
Transcriptional regulation in eukaryotes occurs within a chromatin setting, and is strongly
influenced by the post-translational modification of histones, the building blocks of …

Anticancer activities of histone deacetylase inhibitors

JE Bolden, MJ Peart, RW Johnstone - Nature reviews Drug discovery, 2006 - nature.com
Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …